Transgenic targeting with regulatory elements of the human CD34 gene

Blood

Volumn 100, Issue 13, 2002, Pages 4410-4419

  Radomska, Hanna S ^a,b   Gonzalez, David A ^a,b   Okuno, Yutaka ^a,b   Iwasaki, Hiromi ^a,b   Nagy, Andras ^a,b   Akashi, Koichi ^a,b   Tenen, Daniel G ^a,b   Huettner, Claudia S ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; PROTEIN CD34; RECOMBINASE; RNA; TETRACYCLINE; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ARTIFICIAL CHROMOSOME; BONE MARROW; BREEDING METHOD; CELL ASSAY; CELL LINE; CELL MATURATION; COLONY FORMING CELL; CONTROLLED STUDY; DNA FLANKING REGION; GENE EXPRESSION; GENE ISOLATION; GENE TARGETING; IN VIVO STUDY; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REPORTER GENE; STEM CELL; TRANSGENE; TRANSGENIC MOUSE;

EID: 0037114632     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-02-0355     Document Type: Article

References (63)

1. Civin CI, Strauss LC, Brovall C, Fackler MJ, Schwartz JF, Shaper JH. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol. 1984 33:157-165.
2. Andrews RG, Singer JW, Bernstein ID. Monoclonal antibody 12-8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoitic colony-forming cells and their precursors. Blood. 1986;67:842-845.
3. Fina L, Molgaard HV, Robertson D, et al. Expression, of the CD34 gene in vascular endothelial cells. Blood, 1990;75:2417-2426.
4. Bescorner WE, Civin CI, Strauss LC. Localization of hematopoietic progenitor cells in tissue with the anti-My-10 monoclonal antibody. Am J Pathol. 1985;119:1-4.
5. Vosc MT Burn TC, Wulf G, Lim B, Leone G, Tenen DG. Inhibition of hematopoiesis by competitive binding of the transcription factor PU.1. Proc Natl Acad Sci U S A. 1994;91:7932-7936.
6. Gordon MY, Marley SB, Davidson RJ, et al. Contact-mediated inhibition of human haematopoietic progenitor cell proliferation may be conferred by stem cell antigen, CD34. Hematol J. 2000;1:77-86.
7. Brown J, Greaves MF, Molgaard HV. The gene encoding the stem cell antigen, CD34, is conserved in mouse and expressed in haemopoietic progenitor cell lines, brain, and embryonic fibroblasts. Int Immunol. 1991;3:175-184.
8. Krause DS, Ito T, Fackler MJ, et al. Characterization of murine CD34, a marker for hematopoietic progenitor and stem cells. Blood. 1994;84:691-701.
9. Osawa M, Hanada K, Hamada H, Nakauchi H. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science. 1996;273:242-245.
10. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med. 1996;183:1797-1806.
11. Goodell MA, Rosenzweig M, Kim H, et al. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med. 1997;3:1337-1345.
12. Sato T, Laver JH, Ogawa M. Reversible expression of CD34 by murine hematopoietic stem cells. Blood. 1999;94:2548-2554.
13. Ito T, Tajima F, Ogawa M. Developmental changes of CD34 expression by murine hematopoietic cells. Exp Hematol. 2000;28:1269-1273.
14. Tajima F, Sato T, Lever JH, Ogawa M. CD34 expression by murine hematopoietic stem cells mobilized by granulocyte colony-stimulating factor. Blood. 2000;96:1989-1993.
15. Okuno Y, Iwasaki H, Huettner CS, et al. Differential regulation of the human and murine CD34 genes in hematopoietic stem cells. Proc Natl Acad Sci U S A. 2002;99:6246-6251.
16. Grosveld F, van Assendelft GB, Greaves DR, Kollias G. Position-independent, high-level expression of the human beta-globin gene in transgenic mice. Cell. 1987;51:975-985.
17. Greaves DR, Wilson FD, Lang G, Kioussis D. Human CD2 3′-flanking sequences confer high-level, T cell-specific, position-independent gene expression in transgenic mice. Cell. 1989;56:979-986.
18. Diaz P, Cado D, Winoto A. A locus control region in the T cell receptor alpha/delta locus. Immunity. 1994;1:207-217.
19. Madisen L, Groudine M. Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells. Genes Dev. 1994;8:2212-2226.
20. Bonifer C, Yannoutsos N, Kruger G, Grosveld F, Sippel AE. Dissection of the locus control function located on the chicken lysozyme gene domain in transgenic mice. Nucl Acids Res. 1994;22:4202-4210.
21. Radomska HS, Satterthwaite AB, Burn TC, Oliff IA, Huettner CS, Tenen DG. Multiple control elements are required for expression of the human CD34 gene. Gene. 1998;222:305-318.
22. Satterthwaite AB, Burn TC, Le Beau MM, Tenen DG. Structure of the gene encoding CD34, a human hematopoietic stem cell antigen. Genomics. 1992;12:788-794.
23. Dexter TM, Allen TD, Scott D, Teich NM. Isolation and characterisation of a bipotential haematopoietic cell line. Nature. 1979;277:471-474.
24. Nakayama K, Suwa Y, Mizukami Y, Sogawa K, Fujii-Kuriyama Y. Cloning and sequencing of a novel rat cytochrome P450 2B-encoding gene. Gene. 1993;136:333-336.
25. Radomska HS, Shen CP, Kadesch T, Eckhardt LA. Constitutively expressed Oct-2 prevents immunoglobulin gene silencing in myeloma x T cell hybrids. Immunity. 1994;1:623-634.
26. Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, Bujard H. Transcriptional activation by tetracyclines in mammalian cells. Science. 1995;268:1766-1769.
27. Zhang Y, Buchholz F, Muyrers JP, Stewart AF. A new logic for DNA engineering using recombination in Escherichia coli. Nat Genet. 1998;20:123-128.
28. Muyrers JP, Zhang Y, Testa G, Stewart AF. Rapid modification of bacterial artificial chromosomes by ET-recombination. Nucleic Acids Res. 1999;27:1555-1557.
29. Lakso M, Sauer B, Mosinger B Jr, et al. Targeted oncogene activation by site-specific recombination in transgenic mice. Proc Natl Acad Sci U S A. 1992;89:6232-6236.
30. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A. 1992;89:5547-5551.
31. Huettner CS, Zhang P, Van Etten RA, Tenen DG. Reversibility of acute B-cell leukemia induced by BCR/ABL1. Nat Genet. 2000;24:57-60.
32. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
33. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources rich in ribonuclease. Biochemistry. 1979;18:5294-5299.
34. Iwama A, Zhang P, Darlington GJ, McKercher SR, Maki RA, Tenen DG. Use of RDA analysis of knockout mice to identity myeloid genes regulated in vivo by PU.1 and C/EBPα. Nucl Acids Res. 1998;26:3034-3043.
35. Torczynski RM, Fuke M, Bollon AP. Cloning and sequencing of a humah 18S ribosomal RNA gene. DNA. 1985;4:283-291.
36. Fort P, Marty L, Piechaczyk M, et al. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res. 1985;13:1431-1442.
37. Chen HM, Zhang P, Voso MT, et al. Neutrophils and monocytes express high levels of PU.1 (Spi-1) but not Spi-B. Blood. 1995;85:2918-2928.
38. Sabath DE, Broome HE, Prystowsky MB. Glyceraldehyde-3-phosphate dehydrogenase mRNA is a major interleukin 2-induced transcript in a cloned T-helper lymphocyte. Gene. 1990;91:185-191.
39. Satterthwaite AB, Borson R, Tenen DG. Regulation of the gene for CD34, a human hematopoietic stem cell antigen, in KG-1 cells. Blood. 1990;75:2299-2304.
40. Burn TC, Satterthwaite AB, Tenen DG. The human CD34 hematopoietic stem cell antigen promoter and a 3′ enhancer direct hematopoietic expression in tissue culture. Blood. 1992;80:3051-3059.
41. He XY, Antao VP, Basila D, Marx JC, Davis BR. Isolation and molecular characterization of the human CD34 gene. Blood. 1992;79:2296-2302.
42. Radomska HS, Satterthwaite AB, Taranenko N, Narravula S, Krause DS, Tenen DG. A nuclear factor Y (NFY) site positively regulates the human CD34 stem cell gene. Blood. 1999;94:3772-3780.
43. Suda J, Sudo T, Ito M, Ohno N, Yamaguchi Y, Suda T. Two types of murine CD34 mRNA generated by alternative splicing. Blood. 1992;79:2288-2295.
44. Baumhueter S, Dybdal N, Kyle C, Lasky LA. Global vascular expression of murine CD34, a sialomucin-like endothelial ligand for L-selectin. Blood. 1994;84:2554-2565.
45. Katz FE, Tindle R, Sutherland DR, Greaves MF. Identification of a membrane glycoprotein associated with haemopoietic progenitor cells. Leuk Res. 1985;9:191-198.
46. Okada S, Wang ZQ, Grigoriadis AE, Wagner EF, Vonruden T. Mice lacking C-Fos have normal hematopoietic stem cells but exhibit altered B-cell differentiation due to an impaired bone marrow environment. Mol Cell Biol. 1994;14:382-390.
47. Morel F, Szilvassy SJ, Travis M, Chen B, Galy A. Primitive hematopoietic cells in murine bone marrow express the CD34 antigen. Blood. 1996;88:3774-3784.
48. Spangrude GJ, Heimfeld S, Weissman IL. Purification and characterization of mouse hematopoietic stem cells. Science. 1988;241:58-62.
49. Ogawa M, Matsuzaki Y, Nishikawa S, et al. Expression and function of c-kit in hemopoietic progenitor cells. J Exp Med. 1991;174:63-71.
50. Loken MR, Shah VO, Hollander Z, Civin CI. Flow cytometric analysis of normal B lymphoid development. Pathol Immunopathol Res. 1988;7:357-370.
51. Ishida A, Zeng H, Ogawa M. Expression of lineage markers by CD34(+) hematopoietic stem cells of adult mice. Exp Hematol. 2002;30:361-365.
52. Tajima F, Deguchi T, Laver JH, Zeng H, Ogawa M. Reciprocal expression of CD38 and CD34 by adult murine hematopoietic stem cells. Blood. 2001;97:2618-2624.
53. Matsuoka S, Ebihara Y, Xu Mj, et al. CD34 expression on long-term repopulating hematopoietic stem cells changes during developmental stages. Blood. 2001;97:419-425.
54. Morello D, Moore G, Salmon AM, Yaniv M, Babinet C. Studies on the expression of an H-2K/human growth hormone fusion gene in giant transgenic mice. EMBO J. 1986;1877-1883.
55. Domen J, Cheshier SH, Weissman IL. The role of apoptosis in the regulation of hematopoietic stem cells: Overexpression of Bcl-2 increases both their number and repopulation potential. J Exp Med. 2000;191:253-264.
56. Miles C, Sanchez MJ, Sinclair A, Dzierzak E. Expression of the Ly-6E.1 (Sca-1) transgene in adult hematopoietic stem cells and the developing mouse embryo. Development. 1997;124:537-547.
57. Ogilvy S, Metcalf D, Gibson L, Bath ML, Harris AW, Adams JM. Promoter elements of vav drive transgene expression in vivo throughout the hematopoietic compartment. Blood. 1999;94:1855- 1863.
58. Domen J, Gandy KL, Weissman IL. Systemic overexpression of BCL-2 in the hematopoietic system protects transgenic mice from the consequences of lethal irradiation. Blood. 1998;91:2272-2282.
59. Morrison SJ, Weissman IL. The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity. 1994;1:661-673.
60. Morrison SJ, Hemmati HD, Wandycz AM, Weissman IL. The purification and characterization of fetal liver hematopoietic stem cells. Proc Natl Acad Sci U S A. 1995;92:10302-10306.
61. Randall TD, Weissman IL. Phenotypic and functional changes induced at the clonal level in hematopoietic stem cells after 5-fluorouracil treatment. Blood. 1997;89:3596-3606.
62. Hardy RR, Carmack CE, Shinton SA, Kemp JD, Hayakawa K. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J Exp Med. 1991;173:1213-1225.
63. Okuno Y, Huettner CS, Radomska HS, et al. Distal elements are critical for human CD34 expression in vivo. Blood. 2002;100:4420-4426.